Skip to content

Promus PREMIER™ H7493925216250Recalls & reported problems

Boston Scientific Corporation · Everolimus-Eluting Platinum Chromium Coronary Stent System · Class 3 · Implant

All models of Promus PREMIER (56)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 08714729828860), received between Jul 23, 2018 and Oct 12, 2023 — classified as 2 injuries.

The most frequently reported specific device problem is “Obstruction of Flow” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Obstruction of Flow1

Patient problems

  • Angina1
  • Cardiac Arrest1
  • High Blood Pressure/ Hypertension1
  • Myocardial Infarction1
  • Restenosis1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 12, 2023Obstruction of Flow; Obstruction of Flow

    IT WAS REPORTED THAT RESTENOSIS OCCURRED. ON (B)(6) 2018, THE PATIENT PRESENTED WITH UNSTABLE ANGINA. CORONARY ANGIOGRAPHY REVEALED A BIFURCATED MID LEFT ANTERIOR DESCENDING ARTERY (LAD) WITH 80-90% DISEASE. THE TARGET LESION WAS DIRECTLY STENTED WITH A 16 X 2.50 PROMUS PREMIER DRUG ELUTING STENT RESULTING IN 0% RESIDUAL STENOSIS. THE PATIENT WAS STABLE AND DISCHARGED ON DUAL ANTIPLATELET TREATMENT. ON (B)(6) 2023, THE PATIENT PRESENTED WITH UNSTABLE ANGINA, EXPERIENCING LEFT-SIDED CHEST PAIN RADIATING INTO THE LEFT SHOULDER AND DOWN THE LEFT ARM FOR 2 DAYS. HEPARIN DRIP WAS STARTED, AND THE PATIENT WAS STABLE, AND THEIR PAIN WAS RESOLVED. THE PATIENT WAS DIAGNOSED WITH NON-ST-ELEVATION MYOCARDIAL INFRACTION AND HYPERTENSION. VASCULAR ACCESS WAS OBTAINED VIA THE RIGHT FEMORAL ARTERY. ANGIOGRAPHY REVEALED 99% IN-STENT RESTENOSIS OF THE PREVIOUSLY DEPLOYED PROMUS PREMIER DRUG ELUTING STENT. FOLLOWING PRE-DILATION WITH A 2.00 X 12 EMERGE BALLOON, SUCCESSFUL ANGIOPLASTY WAS PERFORMED USING A 2.75 X 22 NON-BSC DRUG ELUTING STENT. FOLLOWING POST DILATION THERE WAS NO RESIDUAL STENOSIS. THE PATIENT BECAME SEVERELY NAUSEATED AND HYPERTENSIVE POSSIBLY DUE TO A CONTRAST ALLERGY AND WAS GIVEN

    Patient problems: Angina; High Blood Pressure/ Hypertension; Myocardial Infarction; Restenosis

    MAUDE report 17924951 ↗
  • InjuryJul 23, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    SAME CASE AS MDR ID: 2134265-2018-07108, 2134265-2018-07109, 2134265-2018-07110. IT WAS REPORTED THAT PATIENT ¿CODED¿. THE 90% STENOSED TARGET LESION WAS LOCATED IN THE LEFT ANTERIOR DESCENDING (LAD) ARTERY. THE PATIENT ALSO HAD A CHRONIC TOTAL OCCLUSION IN THE RIGHT LAD AS WELL AS SIGNIFICANT DISEASE IN THE CIRCUMFLEX AND IN THE OBTUSE MARGINALS. THERE WERE A TOTAL OF 4 BSC STENTS DEPLOYED IN THE LAD AND ONLY ONE WAS EXPIRED WHICH WAS THE 16 X 2.50 PROMUS PREMIER¿ STENT. THE 3 OTHER STENTS WERE ONE PROMUS OTW AND 2 SYNERGY MR STENTS. THE EXPIRED STENT WAS DISCOVERED AFTER THE CASE, WHEN THE DEVICES USED WERE BEING CONSOLIDATED. THE PROCEDURE WAS COMPLETED AND THE PATIENT WAS FINE. HOWEVER, 3 DAYS POST-PROCEDURE, THE PATIENT CODED. A TEMPORARY PACEMAKER WAS IMPLANTED TO CONTROL THE PATIENT'S HEART RHYTHM. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT WAS RECOVERING.

    Patient problems: Cardiac Arrest

    MAUDE report 7710617 ↗

Other Coronary drug-eluting stent devices

All Coronary drug-eluting stent devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page